In this video, Dr Buse discusses the findings of the OVERCOME Study, in which she and her colleagues investigated the influence of acute treatment optimization on disability and health-related quality of...
Consultant360 spoke with Shiv Saidha, MBBCh, whose study suggests that elevated body mass index may be associated with accelerated ganglion cell + inner plexiform layer atrophy in the absence of overt...
New findings suggest that tau-positron emission tomography signal can predict future brain atrophy in individuals in the early symptomatic stages of Alzheimer disease. The study’s lead author, Renaud La...
Traumatic brain injury affects people of all ages, but children are at high risk especially if they participate in sports. Nicole D. Reams, MD, a sports neurologist at NorthShore University HealthSystem,...
A new study team evaluated whether midlife obesity is a cause of dementia and whether risk factors such as diet or physical inactivity were causes or consequences of the gradual onset of dementia. Lead...
In this commentary, Joe McSherry, MD, PhD, discusses the safety and effectiveness of cannabinoids as alternative treatment options, despite widespread controversy.
Takatoshi Kasai, MD, PhD, and Shoichiro Yatsu, MD, PhD, are the lead authors on a new study that investigated the prevalence of restless legs syndrome in patients with coronary artery disease. Here are...
Barbara Giesser, MD, and Nadine Goldberg, PhD, MS, answer our questions about advocacy in neurology—a topic that will also be discussed at the American Neurological Association’s Annual Meeting.
Barbara Giesser, MD, and Nadine Goldberg, PhD, MS, answer our questions about advocacy in neurology—a topic that will also be discussed at the American Neurological Association’s Annual Meeting.
